Cydan, LLC — Form D/A
Cydan, LLC of Cambridge, MA, a company, filed a Form D amendment with the SEC on 2013-10-02. The offering totals $26.3M, of which $6.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-10-02
- Form: D/A
- Accession: 0001573851-13-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $26.3M
- Amount sold: $6.6M
- Remaining: $19.7M
- Investors: 6
- Date of first sale: 2013-03-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-194829
Issuer
- Name: Cydan, LLC
- CIK: 0001573851
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 300 Technology Square, Cambridge, MA, 02139
- Phone: 617-231-6020
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Cristina Csimma | Director | California, CA |
| Barbara Dalton | Director | New York, NY |
| David Mott | Director | Chevy Chase, MD |
| Sara Nayeem | Director | Menlo Park, CA |
| Christoph M Adams | Executive Officer | CAMBRIDGE, MA |
| Cristina Csimma | Executive Officer | California, CA |
| Deborah M Geraghty | Executive Officer | Cambridge, MA |
| James M McArthur | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More